Relation of fibroblast growth factor-23 and cardiovascular calcification in end-stage kidney disease patients on

Tarek Zakaria El Baz1, Osama Ahmed Khamis1, Osama Ashry Ahmed Gheith2

  • 1Department of Internal Medicine and Nephrology, Faculty of Medicine, Al Azhar University, Cairo, Egypt.

Insights

Elevated fibroblast growth factor 23 (FGF-23) is linked to vascular calcification in end-stage kidney disease (ESKD) patients undergoing hemodialysis (HD). This FGF-23 elevation correlates with aortic and coronary artery calcification, highlighting a significant risk factor.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Cardiovascular disease causes over half of deaths in end-stage kidney disease (ESKD) patients.
  • Elevated fibroblast growth factor 23 (FGF-23) is associated with mortality and peripheral calcification in hemodialysis (HD) patients.
  • Vascular calcification, including aortic and peripheral, is linked to mortality in chronic kidney disease (CKD).

Purpose of the Study:

  • To investigate the relationship between intact FGF-23 and cardiovascular calcification in ESKD patients on regular HD.
  • To assess the prevalence of vascular calcification in this patient group.
  • To explore correlations between FGF-23, calcification, and other risk factors.

Main Methods:

  • Cross-sectional study of 60 clinically stable ESKD patients on regular HD.
  • Evaluation of abdominal aortic calcification via X-ray, with CT scans for coronary artery calcification in affected patients.
  • Assessment of lipid profile, dialysis adequacy, and plasma intact FGF-23 levels.

Main Results:

  • Fifty percent of patients exhibited vascular calcification.
  • Elevated plasma intact FGF-23 was observed in all patients, correlating positively with age, aortic calcification, coronary calcification, lipid profile, left ventricular mass index (LVMI), and inflammatory markers.
  • Significant positive correlations were found between age and FGF-23, and between age, BMI, HD duration, and abdominal aortic calcification score.

Conclusions:

  • Plasma intact FGF-23 is elevated in non-diabetic ESKD patients on HD and correlates significantly with vascular calcification.
  • Vascular calcification is prevalent in this ESKD population, associated with traditional and non-traditional risk factors.
  • FGF-23 may indirectly contribute to vascular calcification through its effects on mineral metabolism and parathyroid hormone.

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
285
Roles of Electrolytes: Calcium and Phosphate01:27

Roles of Electrolytes: Calcium and Phosphate

Calcium and phosphate are essential electrolytes in the human body, with calcium being the most abundant mineral. Around 99% of the body's calcium is stored in the skeleton and teeth, forming a crystal lattice of mineral salts in combination with phosphates. Calcium plays crucial roles in various bodily functions such as blood clotting, neurotransmitter release, muscle tone maintenance, and nervous and muscle tissue excitability.
The calcium concentration in blood plasma is primarily...
1.4K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
561
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
854